Back to Search
Start Over
In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y
- Source :
- Annals of Internal Medicine. 176:JC26
- Publication Year :
- 2023
- Publisher :
- American College of Physicians, 2023.
- Subjects :
- Internal Medicine
General Medicine
Subjects
Details
- ISSN :
- 15393704 and 00034819
- Volume :
- 176
- Database :
- OpenAIRE
- Journal :
- Annals of Internal Medicine
- Accession number :
- edsair.doi...........ddadc427ee264094ff0324fc48970287